Clinical trial
An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine…
NCT00402103 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00402103 |
|---|---|
| Title | An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood Pressure |
| Official title | A 54-week, Open-label, Multicenter Study to Assess the Long-term Safety and Tolerability of the Combination of Aliskiren 300 mg / Amlodipine 10 mg in Patients With Essential Hypertension |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | Aliskiren, Amlodipine, Hydrochlorothiazide |
| Enrollment | 556 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Nov 22, 2006 |
| Last update posted | Mar 10, 2011 |
| Countries | Belgium, Denmark, Finland, Germany, Iceland, India, Switzerland, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: